Advanced Search

Home > Journals > Minerva Chirurgica > Past Issues > Minerva Chirurgica 2016 June;71(3) > Minerva Chirurgica 2016 June;71(3):173-9

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA CHIRURGICA

A Journal on Surgery


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,877

 

Minerva Chirurgica 2016 June;71(3):173-9

 REVIEWS

Time-to-administration in postoperative chemotherapy for colorectal cancer: does minimally-invasive surgery help?

Stefano AMORE BONAPASTA, Paolo CHECCACCI, Francesco GUERRA, Vita M. MIRASOLO, Luca MORALDI, Angelo FERRARA, Mario ANNECCHIARICO, Andrea CORATTI

Division of Oncological and Robotic General Surgery, Careggi University Hospital, Florence, Italy

The optimal delay in the start of chemotherapy following rectal cancer surgery has not yet been identified. However, postponed adjuvant therapy has been proven to be connected with a significant survival detriment. We aimed to investigate whether the time to initiation of adjuvant treatment can be influenced by the application of minimally invasive surgery rather than traditional open surgery. By comprehensively evaluating the available inherent literature, several factors appear to be associated with delayed postoperative chemotherapy. Some of them are strictly related to surgical short-term outcomes. Laparoscopy results in shortened length of hospital stay, reduced surgical morbidity and lower rate of wound infection compared to conventional surgery. Probably due to such advantages, the application of minimally-invasive surgery to treat rectal malignancies seems to impact favorably the possibility to start adjuvant chemotherapy within an adequate timeframe following surgical resection, with potential improvement in patient survival.

language: English


FULL TEXT  REPRINTS

top of page